Lithium Versus Lamotrigine in Bipolar Disorder, Type II
Key facts
- Where
- Copenhagen, DenmarkSee the site
- Phase
- Phase 4
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
Source: NCT06184581, who can take part
Where in Denmark
- Psychiatric Center CopenhagenCopenhagen, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital Bispebjerg and Frederiksberg
- Trial code
- NCT06184581
- Record updated
- 20 March 2026
- Original description
The investigators want in a 6-month randomized controlled trial (RCT) to compare effects of lithium versus lamotrigine on mood stabilization and other critical patient outcomes in patients with BDII.Read full original descriptionShow less
Lithium Versus Lamotrigine in Bipolar Disorder, Type II - a Single Blinded Randomized Controlled Trial (the LiLa-Bipolar RCT)
The investigators want in a 6-month randomized controlled trial (RCT) to compare effects of lithium versus lamotrigine on mood stabilization and other critical patient outcomes in patients with BDII.
Inclusion: Bipolar disorder, type II with diagnosis confirmed by SCAN interview; Age 18-70 years; Habile (i.e., able to give informed consent).
Exclusion: Currently taking mood stabilizers at enrollment in CADIC; Severe chronic kidney disease; Severe cardiac insufficiency; Brugadas syndrome; Past non-response or intolerance to lamotrigine or lithium with > 6 weeks treatment at an adequate dosage; Severe hypothyroidism despite treatment; Women who are pregnant, breastfeeding or planning pregnancy in near future.